TOG Review (RCOG Journal)

MRCOG Part 2

Sexual and Reproductive Health

Intrauterine contraception

Key Statistics

  • 9% — UK women using IUC (community services)
  • 0.2% — LNG-IUS unintended pregnancy, 12 months
  • 2/1000 — Uterine perforation rate at insertion

Don't-miss facts

  1. MHRA: prescribe LNG-IUS by brand name – licences differ (Mirena/Levosert 52 mg vs Jaydess 13.5 mg vs Kyleena 19.5 mg)

  2. Current breast cancer = UKMEC 4 (absolute contraindication); past breast cancer <5 yr = UKMEC 3

  3. Cu-IUD = most effective EC, only method effective after ovulation; fit ≤5 days post-UPSI or ≤day 19 of cycle

  4. Perforation 2/1000 (×6 if breastfeeding postpartum); expulsion ~1 in 20, mostly first 3 months

  5. Cervical shock: bradycardia 1.8%/hypotension 2.1%; if HR <40 bpm sustained → atropine 500–600 µg IV

  6. Postpartum insertion ≤48h (incl. at LSCS): no ↑perforation but ↑expulsion; thread check at 6 weeks

  7. 52-mg LNG-IUS first-line for HMB and for endometrial hyperplasia without atypia (≥6 months, off-licence)

  8. Device 1–2 cm from fundus may be left in situ per FSRH; not seen on USS ≠ expulsion – X-ray to exclude perforation first

Device quick-reference

Mirena 52mg – 5yr contra/HMB, 4yr endo protection Levosert 52mg – 6yr contra, 5yr HMB, no endo licence

Jaydess 13.5mg – 3yr contra only Kyleena 19.5mg – 5yr contra only Cu-IUD 380mm² T-frame – up to 10yr

Abbreviation Key

  • IUC — intrauterine contraception
  • FSRH — Faculty of Sexual and Reproductive Healthcare
  • IUD/IUCD — intrauterine device / intrauterine contraceptive device LoC
  • IUT — Letter of Competence in Intrauterine Techniques
  • LNG-IUS — levonorgestrel-containing intrauterine system
  • PID — pelvic inflammatory disease
  • Cu-IUD — copper intrauterine device
  • STI — sexually transmitted infection
  • LARC — long-acting reversible contraception
  • EC — emergency contraception
  • HMB — heavy menstrual bleeding
  • UPSI — unprotected sexual intercourse
  • PMS/PMDD — premenstrual syndrome / premenstrual dysphoric
  • BASHH — British Association for Sexual Health and HIV disorder
  • hCG — human chorionic gonadotrophin
  • MHT — menopausal hormone therapy
  • DMPA — depot-medroxyprogesterone acetate
  • UKMEC — UK Medical Eligibility Criteria for Contraceptive Use

Source: Ritchie J, Phelan N, Briggs P. Intrauterine contraception. The Obstetrician & Gynaecologist 2021;23:187–195. doi:10.1111/tog.12743

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free